AGI Dermatics Overview

  • Founded
  • 1985
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

AGI Dermatics General Information

Description

Provider of skin diseases and DNA repair treatment solutions. The company was engaged in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system and its proprietary brand, Remergent(R).

Contact Information

Website
www.agiderm.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Acquirer
Primary Office
  • 205 Buffalo Avenue
  • Freeport, NY 11520
  • United States
+1 (516) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AGI Dermatics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 30-Sep-2008 000 Completed Product Development
1. Later Stage VC (Series A) 08-Apr-2008 000 000 0000 Completed Product Development
To view AGI Dermatics’s complete valuation and funding history, request access »

AGI Dermatics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Spring Mountain Capital Growth/Expansion Minority 000 0000 000000 0
Trevi Health Capital Growth/Expansion Minority 000 0000 000000 0
WHI Group Other Minority 000 0000 000000 0
To view AGI Dermatics’s complete investors history, request access »